Primary Care Update Mark Ebell
-
- Health & Fitness
-
Four healthily skeptical primary care physicians discuss the latest in primary care medicine. Join Essential Evidence Editor Mark Ebell MD, Rush University's Kate Rowland MD, MSU Professor of Medicine Gary Ferenchick MD, and POEMs co-founder Henry Barry MD, MS for this fast-paced weekly update on evidence-based primary care.
-
Episode 153: gabapentinoids and COPD, shoulder dislocations, and older Alzheimer's drugs
This week, Mark is taking a break so Kate, Henry and Gary will discuss gabapentinoids and the risk of severe COPD, rehab after an initial anterior shoulder dislocation, and cognitive enhancers for patients with Alzheimer’s dementia
-
Episode 152: SGLT2's for heart failure, bariatric surgery outcomes, UTI in kids, and lung screening outcomes.
Join Kate, Gary, Mark and Henry (who went to the eclipse!) as they discuss SGLT2 inhibitors for older adults and frail adults with heart failure, the long term outcomes of bariatric surgery in adults with T2DM, the best duration of antibiotics for febrile UTI in kids, and real world outcomes of lung cancer screening.
-
Episode 151: SSRIs and mania, oseltamivir, exercise and BP, and HPV vaccine preventing cancer.
Join us today as Gary, Kate, Mark and Henry discuss risks of SSRIs provoking mania in adolescents, real world effectiveness of HPV vaccination for preventing cervical cancer, whether tamiflu reduces hospitalization in adults with flu, and the effects of exercise on BP.
-
Episode 150: EXXUA for depression, ubrogepant for migraine, PCI for stable angina, and a simple way to communications
This week, Gary, Kate, Henry and Mark discuss a newly approved medication for major depression in adults, initiation of abortive therapy using ubrogepant during migraine prodrome, the value of PCI for patients with stable angina, and a simple intervention to improve communication with hospitalized patients. And a quiz!
-
Episode 149: afib risk scores, tai chi and cognition, flu vax, and managing gallstones
This week join us as Kate, Mark, Henry and Gary discuss clinical prediction tool for patients using DOACs for atrial fibrillation, the benefits of cognitively enhanced tai chi, whether high dose recombinant flu vaccine is useful in adults 50-64, and watching patients with symptomatic gallstone disease.
-
Episode 148: meds for alcohol withdrawal, opioids and stimulants, and treating agitation in AD
This week, Kate, Henry and Mark discuss pharmacotherapy for alcohol use disorder, using opioids in adults with cancer pain who also use non-medical stimulants, and brexpiprazole for agitation in patients with Alzheimer's dementia.
Customer Reviews
Great perspectives, love the humor
I’m a new listener but already a huge fan. The hosts are fantastic and I appreciate the approach—very well informed but realistic and pragmatic as far as what we can actually achieve in the primary care setting and staying focused on patient centered goals. Love the humor and skepticism/borderline mistrust of the medical establishment when discussing new drugs and trials. Highly recommend for primary care and family med providers.
Love the show but…
I really like the content but sometimes I just have to stop listening because the background noise is too annoying. Just mute your mics when not talking please .
Great show
Love the dynamics between the hosts and the studies they present. The sound is very poor with sometimes a lot of background noise but still great show, great EBM.